الفهرس 
EPIDEMILOGY OF HCV HEPATITISOnly 14 pages are availabe for public view
 |  | from | 139 |  |  |
| | | from | 139 | | |
Abstract
1-The present study comprised seventy five (75) patients; fourty seven (47) males and twenty eight (28) females with an age ranging from twelve (12) to seventy (70) years. They had a history of blood and/or fluid transfusion and they were all HBsAg negative. 2-In decreasing order of frequency, transfusion .associated HCV antibody reactivity in the studied high risk groups was: 84.2% in haematemesis and/or melaena group, 80% in oncology group, 66.6% in chronic haemodialysis group, 58.8% in postoperative transfusion group and 45.4% in bronchial asthma group. 3-It seems that the risk for catching HCV infection does not necessitate transfusion of blood or its components but it is the parenteral route per se that is to be incriminated. 4-Not only blood or fluid transfusion but also impaired immunity by the disease or its treatment and repeated tissue punctures are risk factors for catching HCV infection. 5-HCV transfusion associated infection has a high incidence of asymptomatic carriers as many patients did not have clinical features of definite hepatic illness.